Farmasian teknologian ja biofarmasian laitos
Department of Pharmaceutics

Julkaisut 1995
Publications 1995

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Auriola S et al. CE-MS and MS-MS analyses of lipopolysaccharides from p.aeruginosa.
2 Hirvonen J et al. Current profile regulates iontophoretic delivery of amino acids across the skin.
3 Hirvonen J et al. Current profile regulates transdermal iontophoresis of amino acids.
4 Jaervinen T et al., inventor. Novel pilocarpine derivatives and process for their preparation.
5 Jaervinen T et al., inventor. Composition for ophthalmic use.
6 Jarho P et al. Hydroxypropyl-ß-cyclodextrin increases the aqueous solubility and stability of pilocarpine prodrugs.
7 Järvinen K et al. Ocular absorption following topical delivery.
8 Järvinen T et al. ß-cyclodextrin derivatives, SBE4-ß-CD and HP-ß-CD, increase the oral bioavailability of cinnarizine in beagle dogs.
9 Järvinen T et al. Sulfobutyl ether ß-cyclodextrin (SBE-ß-CD) in eyedrops improves the tolerability of a topically applied pilocarpine prodrug in rabbits.
10 Järvinen T et al., inventor. Bispilocarpic acid ester derivatives and process for their preparation.
11 Järvinen T et al., inventor. Novel pilocarpine derivatives and process for their preparation.
12 Järvinen T et al., inventor. Novel pilocarpine derivatives and process for their preparation.
13 Järvinen T et al., inventor. Novel pilocarpine derivatives and process for their preparation.
14 Järvinen T et al., inventor. Novel pilocarpine derivatives and process for their preparation.
15 Järvinen T et al. Comparison of enzymatic hydrolysis of pilocarpine prodrugs in human plasma, rabbit cornea, and butyrylcholinesterase solutions.
16 Järvinen T et al., inventor. Composition for ophthalmic use.
17 Ketolainen J. Evaluation of Changes in Physical Properties of Tablets and Tableting Materials due to Mechanical and Thermal Stress.
18 Ketolainen J et al. Thermophysical properties of some pharmaceutical excipients compressed in tablets.
19 Ketolainen J et al. Photoacoustic investigation of tablet integrity.
20 Ketolainen J et al. Photoacoustic evaluation of elasticity and integrity of pharmaceutical tablets.
21 Ketolainen J et al. Changes in solid-state structure of cyclophosphamide monohydrate induced by mechanical treatment and storage.
22 Ketolainen J et al. Characterization of physical properties of theophylline and its polymorphs.
23 Makkonen N et al. The effect of free gallium and gallium in liposomes on cytokine and nitric oxide secretion from macrophage-like cells in vitro.
24 Mönkkönen J et al. Studies on liposome formulations for intra-articular delivery of clodronate.
25 Nurmi T et al. Kipulääkekasettien täyttäminen apteekeissa -steriiliystutkimus.
26 Paronen P, Ilkka J. Porosity-pressure functions.
27 Pate DW et al. Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits.
28 Pennanen N et al. Macrophage-like RAW 264 cell line and time-resolved fluoroimmunoassay (TRFIA) as tools in screening drug effects on cytokine secretion.
29 Pennanen N et al. Effect of liposomal and free bisphosphonates on the IL-1ß, IL-6 and TNFAlfa secretion from RAW 264 cells in vitro.
30 Pesonen T et al. The incompatibilities between chlorhexidine diacetate and some tablet excipients.
31 Pirttilä T-RM et al. Glucose metabolism in the developing cerebral cortex as detected by 1H {13C} nuclear magnetic resonance spectroscopy ex vivo.
32 Raatikainen P et al. Evaluation of elasticity and homogeneity of compacts by double-exposure holographic interferometry.
33 Saarinen-Savolainen P et al. Voidaanko eläinkokeet korvata in vitro -menetelmillä silmä-ärsytystutkimuksissa.
34 Suhonen P et al. Ocular absorption and irritation of pilocarpine prodrug is modified with buffer, polymer, and cyclodextrin in the eyedrop.
35 Sutinen R et al. pH-controlled silicone microspheres for controlled drug delivery.
36 Taipale HT et al. Triterpenes from betula pendula decrease liposome stability, are hemolytic, and inhibit hepatoma cell growth.
37 Tirkkonen S et al. Buffer controlled release of indomethacin from ethylcellulose microcapsules.
38 Urtti A. Kinetic aspects in the design of prolonged action ocular drug delivery systems.
39 Urtti A. Mechanisms of transdermal penetration enhancement.
40 Urtti A et al., inventor. Composition for ophthalmic use.
41 Urtti A et al., uppfinnare. Komposition för topisk administration av bispilokarpinsyradiestrar till ögat i form av en vattenlösning.
42 Urtti A et al., inventor. Composition for ophthalmic use.
43 Urtti A et al., uppfinnare. Komposition för topisk administration av bispilokarpinsyradiestrar till ögat i form av en vattenlösning.
44 Vidgren M et al. Clinical equivalence of a novel multiple dose powder inhaler versus a conventional metered dose inhaler on bronchodilating effects of salbutamol.
45 Vidgren M et al. Easyhaler multiple dose powder inhaler-practical and effective alternative to the pressurized MDI.
46 Vidgren M et al. A study of 99m technetium-labelled beclomethasone dipropionate dilauroylphosphatidylcholine liposome aerosol in normal volunteers.

Farmasian teknologian ja biofarmasian laitos Department of Pharmaceutics
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008